Viva Las Vegas! We will see you at PAINWeek 2026, September 8-11 at The Cosmopolitan of Las Vegas. Each year, the conference continues to be the ultimate destination for professionals seeking the most comprehensive and cutting-edge curriculum in pain management. With acute and chronic pain conditions affecting millions, pain research is a critical area for innovation. Rho’s expertise is built around our coordinated execution where teams are aligned, work cross-functionally, and support sites to make trials run smoother. Because we know that better pain treatments start with better trials. So, let’s meet up in Vegas and work together to build a study designed for real impact.

Rho is pleased to return to San Diego for the 14th Annual Outsourcing in Clinical Trials Southern California event—an event that brings together leaders from sponsors, biotech, and CROs to exchange practical insights and build partnerships. Our team appreciates this time to connect with our peers, discover new solutions, and leave with actionable strategies to take back with us. If you’re looking for a trusted ally in clinical development who will work alongside you to advance science, improve patient outcomes, and bring treatments to market, then spend some time with us. While science can be complex, we get working with your CRO shouldn’t be. Let’s meet and build something great together!

We are excited to participate in the ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop, a grassroots-style, cross-industry meeting bringing statisticians together to have conversations on the field’s most pressing topics. Founded 40 years ago as a biometrics-focused company, Rho has built a reputation for delivering high-quality statistical expertise and data-driven solutions. Today, that legacy continues as we apply advanced methodologies to turn complex data into clear, actionable insights. Attending the event in Rockville, MD? Let’s get together to crunch the numbers, so you can see how our end-to-end biometrics services support clinical development and regulatory success.

Rho is traveling west to Denver, CO, for SOCRA’s Annual Conference, September 25-27, where more than 1,000 clinical research professionals will come together for educational sessions, best practice sharing, and networking across the global research community. With our full-service expertise, what better place for our team to be? We know that executing clinical trials requires more than the right strategy; it demands seamless execution, quality oversight, and proactive risk management. From expert project management to pharmacovigilance, we provide the foundation that makes breakthroughs possible. Interested in staying at the forefront of advancements in clinical research? Talk to our team in “The Mile High City” to learn how Rho provides the insight to drive trial success.

Heading to Orlando for the Global Sites Solutions Summit? So are we! We are excited to be back in “The Sunshine State” to connect with investigators and dive into site engagement strategies to prepare for the future of clinical research. Our team knows that one secret to running better and smoother clinical trials is strong site relationships—and the true nature of these partnerships can determine the outcome of trials. That’s why, at Rho, being site-centric isn’t just a talking point, but it’s a value built into our work. While you’re in Florida, connect with our site experts and discover what site-centricity really means in practice.

Our team is heading to the CNS Summit in Boston, November 1-4, joining leaders across neuroscience, innovation, and clinical research. With deep expertise in CNS clinical trials—spanning movement disorders, neurogenerative diseases, and rare CNS diseases—as well as a commitment to meaningful partnerships, Rho is proud to be a contributor in some of the most complex areas of research. If you catch us taking in the views of the harbor or walking along the Freedom Trail between sessions, come say hello. We’d love to connect, talk about science, and find ways to collaborate to advance CNS research.